
Sanofi is exploring a takeover of Insmed Inc in a deal that would value the United States drugmaker above its current $26.28B market capitalization, people familiar with the matter said on Thursday afternoon.
French drugmaker Sanofi is reportedly exploring a potential takeover of United States pharmaceutical company Insmed. Deliberations remain ongoing and any finalized agreement could still be weeks away.

Sanofi is exploring a takeover of Insmed Inc in a deal that would value the United States drugmaker above its current $26.28B market capitalization, people familiar with the matter said on Thursday afternoon.
ทุกอย่างที่คุณใช้บนเว็บ เร็วกว่าและอยู่ในมือคุณ